Product Description: Tafamidis meglumine (Fx-1006A) is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis meglumine inhibits amyloidogenesis[1].
Applications: Neuroscience-Neuromodulation
Formula: C21H24Cl2N2O8
Citations: Vascul Pharmacol. 2024 Jul 17:107411./J Med Chem. 2021 Sep 21.
References: [1]Bulawa CE, et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9629-34.
CAS Number: 951395-08-7
Molecular Weight: 503.33
Compound Purity: 99.79
Research Area: Neurological Disease
Solubility: DMSO : 12.5 mg/mL (ultrasonic)/H2O : < 0.1 mg/mL
Target: Transthyretin (TTR)